Previous 10 | Next 10 |
2024-03-13 11:06:04 ET More on NeuroBo Pharmaceuticals NeuroBo stock jumps 14% on weight-loss drug update NeuroBo to begin Phase 1 testing of potential Wegovy rival Seeking Alpha’s Quant Rating on NeuroBo Pharmaceuticals Historical earnings data for Ne...
2024-03-13 08:29:15 ET Read the full article on Seeking Alpha For further details see: KB Financial, BeiGene, Legend Biotech among premarket gainers' pack
NeuroBo Pharmaceuticals Receives Safety Review Committee Approval to Continue With Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH PR Newswire Blinded Safety Review Completed for the First 6 Months of the Phase 2a Clinical Trial Conduct; Recommending T...
NeuroBo Pharmaceuticals Receives First Site IRB Approval for Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity PR Newswire First Patient Expected to be Randomized in the Second Quarter of 2024 CAMBRIDGE, Mass. , Feb. 29, 2024 /PRN...
2024-02-27 04:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-16 09:10:00 ET February 16, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech sector. The newest biotech companies are involved in treatment of heart disease, ...
NeuroBo Pharmaceuticals to Participate in the BIO CEO & Investor Conference NeuroBo Pharmaceuticals to Participate in the BIO CEO & Investor Conference PR Newswire CAMBRIDGE, Mass. , Feb. 12, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nas...
2024-02-05 11:18:38 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Last week, the Federal Reserve’s interest rate decision and the latest non-farm payroll (NFP) data dictated the stock market’s performance. During heightened volatility, a handful...
2024-02-02 09:52:50 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Lilly, Zoetis, Abbott least shor...
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) fell 3.4% to $12.34 on volume of 161,376,033 shares New York Community Bancorp Inc. (NYCB) fell 11.1% to $5.75 on volume of 125,980,698 shares Plug Power Inc. (PLUG) rose 5.6% to $4.7 on volume of 111,112,179 sh...
News, Short Squeeze, Breakout and More Instantly...
NeuroBo Pharmaceuticals Inc. Company Name:
NRBO Stock Symbol:
NASDAQ Market:
NeuroBo Pharmaceuticals Inc. Website:
NeuroBo Pharmaceuticals Announces Exclusive License Agreement with MThera Pharma for NB-01 PR Newswire CAMBRIDGE, Mass. , July 30, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transfo...
NeuroBo Pharmaceuticals Doses First Patient in the MAD Part 2 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity PR Newswire Top-Line Data Readout From the Single Ascending Dose Part 1 Expected in the Third Quarter of 2024, and From the Multiple Asce...
NeuroBo Pharmaceuticals Announces the Closing of up to $70 Million Concurrent Private Placement and Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire $20 million upfront with up to an additional $50 million of aggregate gross proceeds upon ...